Copyright Reports & Markets. All rights reserved.

Global Gastrointestinal Drugs Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Gastrointestinal Drugs Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Gastrointestinal Drugs Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Gastrointestinal Drugs Market Size Growth Rate by Type
    • 1.4.2 Prescription Gastrointestinal Drug
    • 1.4.3 OTC Gastrointestinal Drug
  • 1.5 Market by Application
    • 1.5.1 Global Gastrointestinal Drugs Market Size Growth Rate by Application
    • 1.5.2 Chronic Gastritis
    • 1.5.3 Functional Dyspepsia
    • 1.5.4 Peptic Ulcer
    • 1.5.5 Acute Gastroenteritis
    • 1.5.6 Other
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Gastrointestinal Drugs Market Size, Estimates and Forecasts
    • 2.1.1 Global Gastrointestinal Drugs Revenue 2015-2026
    • 2.1.2 Global Gastrointestinal Drugs Sales 2015-2026
  • 2.2 Global Gastrointestinal Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Gastrointestinal Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Gastrointestinal Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Gastrointestinal Drugs Competitor Landscape by Players

  • 3.1 Gastrointestinal Drugs Sales by Manufacturers
    • 3.1.1 Gastrointestinal Drugs Sales by Manufacturers (2015-2020)
    • 3.1.2 Gastrointestinal Drugs Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Gastrointestinal Drugs Revenue by Manufacturers
    • 3.2.1 Gastrointestinal Drugs Revenue by Manufacturers (2015-2020)
    • 3.2.2 Gastrointestinal Drugs Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Gastrointestinal Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Gastrointestinal Drugs Revenue in 2019
    • 3.2.5 Global Gastrointestinal Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Gastrointestinal Drugs Price by Manufacturers
  • 3.4 Gastrointestinal Drugs Manufacturing Base Distribution, Product Types
    • 3.4.1 Gastrointestinal Drugs Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Gastrointestinal Drugs Product Type
    • 3.4.3 Date of International Manufacturers Enter into Gastrointestinal Drugs Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Gastrointestinal Drugs Market Size by Type (2015-2020)
    • 4.1.1 Global Gastrointestinal Drugs Sales by Type (2015-2020)
    • 4.1.2 Global Gastrointestinal Drugs Revenue by Type (2015-2020)
    • 4.1.3 Gastrointestinal Drugs Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Gastrointestinal Drugs Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Gastrointestinal Drugs Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Gastrointestinal Drugs Revenue Forecast by Type (2021-2026)
    • 4.2.3 Gastrointestinal Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Gastrointestinal Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Gastrointestinal Drugs Market Size by Application (2015-2020)
    • 5.1.1 Global Gastrointestinal Drugs Sales by Application (2015-2020)
    • 5.1.2 Global Gastrointestinal Drugs Revenue by Application (2015-2020)
    • 5.1.3 Gastrointestinal Drugs Price by Application (2015-2020)
  • 5.2 Gastrointestinal Drugs Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Gastrointestinal Drugs Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Gastrointestinal Drugs Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Gastrointestinal Drugs Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Gastrointestinal Drugs by Country
    • 6.1.1 North America Gastrointestinal Drugs Sales by Country
    • 6.1.2 North America Gastrointestinal Drugs Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Gastrointestinal Drugs Market Facts & Figures by Type
  • 6.3 North America Gastrointestinal Drugs Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Gastrointestinal Drugs by Country
    • 7.1.1 Europe Gastrointestinal Drugs Sales by Country
    • 7.1.2 Europe Gastrointestinal Drugs Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Gastrointestinal Drugs Market Facts & Figures by Type
  • 7.3 Europe Gastrointestinal Drugs Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Gastrointestinal Drugs by Region
    • 8.1.1 Asia Pacific Gastrointestinal Drugs Sales by Region
    • 8.1.2 Asia Pacific Gastrointestinal Drugs Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Gastrointestinal Drugs Market Facts & Figures by Type
  • 8.3 Asia Pacific Gastrointestinal Drugs Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Gastrointestinal Drugs by Country
    • 9.1.1 Latin America Gastrointestinal Drugs Sales by Country
    • 9.1.2 Latin America Gastrointestinal Drugs Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Gastrointestinal Drugs Market Facts & Figures by Type
  • 9.3 Central & South America Gastrointestinal Drugs Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Gastrointestinal Drugs by Country
    • 10.1.1 Middle East and Africa Gastrointestinal Drugs Sales by Country
    • 10.1.2 Middle East and Africa Gastrointestinal Drugs Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Gastrointestinal Drugs Market Facts & Figures by Type
  • 10.3 Middle East and Africa Gastrointestinal Drugs Market Facts & Figures by Application

11 Company Profiles

  • 11.1 AstraZeneca
    • 11.1.1 AstraZeneca Corporation Information
    • 11.1.2 AstraZeneca Description and Business Overview
    • 11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 AstraZeneca Gastrointestinal Drugs Products Offered
    • 11.1.5 AstraZeneca Related Developments
  • 11.2 Sanofi
    • 11.2.1 Sanofi Corporation Information
    • 11.2.2 Sanofi Description and Business Overview
    • 11.2.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Sanofi Gastrointestinal Drugs Products Offered
    • 11.2.5 Sanofi Related Developments
  • 11.3 Bayer
    • 11.3.1 Bayer Corporation Information
    • 11.3.2 Bayer Description and Business Overview
    • 11.3.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Bayer Gastrointestinal Drugs Products Offered
    • 11.3.5 Bayer Related Developments
  • 11.4 Pfizer
    • 11.4.1 Pfizer Corporation Information
    • 11.4.2 Pfizer Description and Business Overview
    • 11.4.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Pfizer Gastrointestinal Drugs Products Offered
    • 11.4.5 Pfizer Related Developments
  • 11.5 GlaxoSmithKline
    • 11.5.1 GlaxoSmithKline Corporation Information
    • 11.5.2 GlaxoSmithKline Description and Business Overview
    • 11.5.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 GlaxoSmithKline Gastrointestinal Drugs Products Offered
    • 11.5.5 GlaxoSmithKline Related Developments
  • 11.6 Teva
    • 11.6.1 Teva Corporation Information
    • 11.6.2 Teva Description and Business Overview
    • 11.6.3 Teva Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Teva Gastrointestinal Drugs Products Offered
    • 11.6.5 Teva Related Developments
  • 11.7 Zeria（Tillotts）
    • 11.7.1 Zeria（Tillotts） Corporation Information
    • 11.7.2 Zeria（Tillotts） Description and Business Overview
    • 11.7.3 Zeria（Tillotts） Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Zeria（Tillotts） Gastrointestinal Drugs Products Offered
    • 11.7.5 Zeria（Tillotts） Related Developments
  • 11.8 Perrigo
    • 11.8.1 Perrigo Corporation Information
    • 11.8.2 Perrigo Description and Business Overview
    • 11.8.3 Perrigo Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Perrigo Gastrointestinal Drugs Products Offered
    • 11.8.5 Perrigo Related Developments
  • 11.9 Boehringer Ingelheim
    • 11.9.1 Boehringer Ingelheim Corporation Information
    • 11.9.2 Boehringer Ingelheim Description and Business Overview
    • 11.9.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Boehringer Ingelheim Gastrointestinal Drugs Products Offered
    • 11.9.5 Boehringer Ingelheim Related Developments
  • 11.10 Purdue Pharma
    • 11.10.1 Purdue Pharma Corporation Information
    • 11.10.2 Purdue Pharma Description and Business Overview
    • 11.10.3 Purdue Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Purdue Pharma Gastrointestinal Drugs Products Offered
    • 11.10.5 Purdue Pharma Related Developments
  • 11.1 AstraZeneca
    • 11.1.1 AstraZeneca Corporation Information
    • 11.1.2 AstraZeneca Description and Business Overview
    • 11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 AstraZeneca Gastrointestinal Drugs Products Offered
    • 11.1.5 AstraZeneca Related Developments
  • 11.12 Abbott
    • 11.12.1 Abbott Corporation Information
    • 11.12.2 Abbott Description and Business Overview
    • 11.12.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 Abbott Products Offered
    • 11.12.5 Abbott Related Developments
  • 11.13 Jiangzhong
    • 11.13.1 Jiangzhong Corporation Information
    • 11.13.2 Jiangzhong Description and Business Overview
    • 11.13.3 Jiangzhong Sales, Revenue and Gross Margin (2015-2020)
    • 11.13.4 Jiangzhong Products Offered
    • 11.13.5 Jiangzhong Related Developments
  • 11.14 Xian-Janssen
    • 11.14.1 Xian-Janssen Corporation Information
    • 11.14.2 Xian-Janssen Description and Business Overview
    • 11.14.3 Xian-Janssen Sales, Revenue and Gross Margin (2015-2020)
    • 11.14.4 Xian-Janssen Products Offered
    • 11.14.5 Xian-Janssen Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Gastrointestinal Drugs Market Estimates and Projections by Region
    • 12.1.1 Global Gastrointestinal Drugs Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Gastrointestinal Drugs Revenue Forecast by Regions 2021-2026
  • 12.2 North America Gastrointestinal Drugs Market Size Forecast (2021-2026)
    • 12.2.1 North America: Gastrointestinal Drugs Sales Forecast (2021-2026)
    • 12.2.2 North America: Gastrointestinal Drugs Revenue Forecast (2021-2026)
    • 12.2.3 North America: Gastrointestinal Drugs Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Gastrointestinal Drugs Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Gastrointestinal Drugs Sales Forecast (2021-2026)
    • 12.3.2 Europe: Gastrointestinal Drugs Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Gastrointestinal Drugs Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Gastrointestinal Drugs Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Gastrointestinal Drugs Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Gastrointestinal Drugs Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Gastrointestinal Drugs Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Gastrointestinal Drugs Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Gastrointestinal Drugs Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Gastrointestinal Drugs Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Gastrointestinal Drugs Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Gastrointestinal Drugs Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Gastrointestinal Drugs Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Gastrointestinal Drugs Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Gastrointestinal Drugs Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Gastrointestinal Drugs Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Gastrointestinal Drugs Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Gastrointestinal Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Gastrointestinal Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Gastrointestinal Drugs market is segmented into
    Prescription Gastrointestinal Drug
    OTC Gastrointestinal Drug

    Segment by Application, the Gastrointestinal Drugs market is segmented into
    Chronic Gastritis
    Functional Dyspepsia
    Peptic Ulcer
    Acute Gastroenteritis
    Other

    Regional and Country-level Analysis
    The Gastrointestinal Drugs market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Gastrointestinal Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Gastrointestinal Drugs Market Share Analysis
    Gastrointestinal Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Gastrointestinal Drugs business, the date to enter into the Gastrointestinal Drugs market, Gastrointestinal Drugs product introduction, recent developments, etc.

    The major vendors covered:
    AstraZeneca
    Sanofi
    Bayer
    Pfizer
    GlaxoSmithKline
    Teva
    Zeria（Tillotts）
    Perrigo
    Boehringer Ingelheim
    Purdue Pharma
    C.B. Fleet
    Abbott
    Jiangzhong
    Xian-Janssen

    Buy now